RobCo Secures $100 million to Scale Autonomous Industrial Robotics
HQ: DE
Founded: 2020
Series C
Sector: Industrial Automation, Robotics
Investment Raised: USD 100m €
Valuation Remains Undisclosed
Investors: The round was co-led by Lightspeed Venture Partners and Lingotto Innovation, an investment firm owned by Exor, with participation from Sequoia Capital, Greenfield Partners, Kindred Capital, Leitmotif, and The Friedkin Group
Green Energy Origin completed a Series B financing round of $110 million, with Light Source Capital serving as the exclusive financial advisor.
HQ: DE
Founded: 2023
Series B
Sector: Battery Manufacturing Renewable Energy, Renewable Energy
Investment Raised: USD 110m €
Valuation Remains Undisclosed
Investors: This round was led by BlueCrest Capital Management, joined by Qiming Venture Partners, as a new investor, along with existing shareholders Sofina, HSG, and NIO Capital. Light Capital served as the exclusive financial advisor for this round.
Black Forest Labs raises $300M at $3.25B valuation
HQ: DE
Founded: 2024
Series B
Investment Raised: USD 300m €
EUR 3.25b
Valuation
Investors: The round was co-led by Salesforce Ventures and Anjney Midha (AMP), and saw participation from a16z, NVIDIA, Northzone, Creandum, Earlybird VC, BroadLight Capital, General Catalyst, Temasek, Bain Capital Ventures, Air Street Capital, Visionaries Club, Canva, and Figma Ventures.
Munich-based Tubulis secures €308 million to advance antibody-drug conjugate innovation
HQ: DE
Founded: 2012
Series C
Sector: Biotechnology
Investment Raised: EUR 308m €
Valuation Remains Undisclosed
Investors: Led by Venrock Healthcare Capital Partners, with participation from Wellington Management and Ascenta Capital, alongside existing investors including Nextech Invest, EQT Life Sciences, Frazier Life Sciences, Andera Partners, Deep Track Capital, Bayern Kapital, Fund+, OCCIDENT, Seventure Partners, and HTGF.
Munich-based Tubulis secures €308 million to advance antibody-drug conjugate innovation
HQ: DE
Founded: 2012
Series C
Sector: Biotechnology
Investment Raised: EUR 308m €
Valuation Remains Undisclosed
Investors: Led by Venrock Healthcare Capital Partners, with participation from Wellington Management and Ascenta Capital, alongside existing investors including Nextech Invest, EQT Life Sciences, Frazier Life Sciences, Andera Partners, Deep Track Capital, Bayern Kapital, Fund+, OCCIDENT, Seventure Partners, and HTGF.
n8n Secures $180 Million Series C Funding, Hits $2.5 Billion Valuation to Lead AI-Powered Workflow Automation
HQ: DE
Founded: 2019
Series C
Sector: Artificial Intelligence
Investment Raised: USD 180m €
USD 2.5b
Valuation
Investors: Led by Accel, with support from Meritech, Redpoint, Evantic and Visionaries Club. Corporate investors NVentures (NVIDIA’s venture capital arm) and T.Capital also join the round, with previous backers including Felicis Ventures, Sequoia, Highland Europe and HV Capital making follow-on investments.
